fluoxetine has been researched along with Hyperglycemia in 9 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
Excerpt | Relevance | Reference |
---|---|---|
" Several experimental groups were tested: (a) animals that were subjected to long-term (42-day) alloxan-hyperglycemia and protected with insulin, (b) healthy animals that received a low dose of insulin that does not produce changes in glycemia, and (c) animals that received long-term treatment with fluoxetine." | 7.91 | Responsivity of lateral septum-mPFC connections in alloxan-induced hyperglycemia. ( Contreras, CM; Gutiérrez-García, AG; Moreno-Cortés, ML, 2019) |
" Both fluoxetine and fluvoxamine elicited significant hyperglycemia, while a selective noradrenaline reuptake inhibitor maprotiline had no effect." | 7.70 | Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms. ( Inoue, K; Sugimoto, Y; Yamada, J, 1999) |
"Fluoxetine treatment did not affect the 5-HT effect on food intake amount but significantly reduced the 5-HT effect on feeding latency." | 5.33 | Chronic fluoxetine administration desensitizes the hyperglycemia but not the anorexia induced by serotonin in rats receiving fructose-enriched chow. ( Cheng, JT; Chung, HH; Hsiao, SH; Tong, YC, 2006) |
" Several experimental groups were tested: (a) animals that were subjected to long-term (42-day) alloxan-hyperglycemia and protected with insulin, (b) healthy animals that received a low dose of insulin that does not produce changes in glycemia, and (c) animals that received long-term treatment with fluoxetine." | 3.91 | Responsivity of lateral septum-mPFC connections in alloxan-induced hyperglycemia. ( Contreras, CM; Gutiérrez-García, AG; Moreno-Cortés, ML, 2019) |
" They also had mature onset obesity characterized by a dramatic 80-150% increase in body weight, increased linear growth, and elevated serum levels of leptin, insulin, glucose, and cholesterol." | 3.71 | Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. ( Bates, B; Fan, G; Fekete, C; Jaenisch, R; Kelly, J; Kuehn, R; Lechan, RM; Rios, M, 2001) |
" Both fluoxetine and fluvoxamine elicited significant hyperglycemia, while a selective noradrenaline reuptake inhibitor maprotiline had no effect." | 3.70 | Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms. ( Inoue, K; Sugimoto, Y; Yamada, J, 1999) |
"Weight loss was significantly higher in the fluoxetine-treated patients, whose diabetic status improved." | 2.67 | Fluoxetine therapy in obese diabetic and glucose intolerant patients. ( Daubresse, JC; Friedman, H; Kolanowski, J; Krzentowski, G; Kutnowski, M; Scheen, A; Van Gaal, L, 1992) |
"Fluoxetine treatment did not affect the 5-HT effect on food intake amount but significantly reduced the 5-HT effect on feeding latency." | 1.33 | Chronic fluoxetine administration desensitizes the hyperglycemia but not the anorexia induced by serotonin in rats receiving fructose-enriched chow. ( Cheng, JT; Chung, HH; Hsiao, SH; Tong, YC, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pereira, MM | 1 |
de Morais, H | 1 |
Dos Santos Silva, E | 1 |
Corso, CR | 1 |
Adami, ER | 1 |
Carlos, RM | 1 |
Acco, A | 1 |
Zanoveli, JM | 1 |
Contreras, CM | 1 |
Gutiérrez-García, AG | 1 |
Moreno-Cortés, ML | 1 |
El-Marasy, SA | 1 |
Abdallah, HM | 1 |
El-Shenawy, SM | 1 |
El-Khatib, AS | 1 |
El-Shabrawy, OA | 1 |
Kenawy, SA | 1 |
Hsiao, SH | 1 |
Chung, HH | 1 |
Tong, YC | 1 |
Cheng, JT | 1 |
Erenmemisoglu, A | 1 |
Ozdogan, UK | 1 |
Saraymen, R | 1 |
Tutus, A | 1 |
Yamada, J | 1 |
Sugimoto, Y | 1 |
Inoue, K | 1 |
Santos, EA | 1 |
Keller, R | 1 |
Rodriguez, E | 1 |
Lopez, L | 1 |
Rios, M | 1 |
Fan, G | 1 |
Fekete, C | 1 |
Kelly, J | 1 |
Bates, B | 1 |
Kuehn, R | 1 |
Lechan, RM | 1 |
Jaenisch, R | 1 |
Kutnowski, M | 1 |
Daubresse, JC | 1 |
Friedman, H | 1 |
Kolanowski, J | 1 |
Krzentowski, G | 1 |
Scheen, A | 1 |
Van Gaal, L | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of a Weight Management Program on Body Weight in Individuals Who Are Overweight and Otherwise Healthy[NCT04107155] | 54 participants (Actual) | Interventional | 2019-07-23 | Completed | |||
A Randomized Controlled Trial to Evaluate the Effects of Repeated Periods of Modified Fasting to Support Healthy Natural Weight Management and Prevention of Weight Gain in Overweight But Generally Healthy Adults Over the Winter Holiday Period[NCT03372109] | 23 participants (Actual) | Interventional | 2017-11-14 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for fluoxetine and Hyperglycemia
Article | Year |
---|---|
Fluoxetine therapy in obese diabetic and glucose intolerant patients.
Topics: Blood Glucose; Diabetes Mellitus; Double-Blind Method; Female; Fluoxetine; Glucose Tolerance Test; G | 1992 |
8 other studies available for fluoxetine and Hyperglycemia
Article | Year |
---|---|
The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antioxidants; Anxiety; Behavior, Animal; Depres | 2018 |
Responsivity of lateral septum-mPFC connections in alloxan-induced hyperglycemia.
Topics: Alloxan; Animals; Antidepressive Agents; Brain; Diabetes Mellitus, Experimental; Fear; Fluoxetine; H | 2019 |
Anti-depressant effect of hesperidin in diabetic rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Brain-Derived Neurotrophic Fa | 2014 |
Anti-depressant effect of hesperidin in diabetic rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Brain-Derived Neurotrophic Fa | 2014 |
Anti-depressant effect of hesperidin in diabetic rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Brain-Derived Neurotrophic Fa | 2014 |
Anti-depressant effect of hesperidin in diabetic rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Brain-Derived Neurotrophic Fa | 2014 |
Chronic fluoxetine administration desensitizes the hyperglycemia but not the anorexia induced by serotonin in rats receiving fructose-enriched chow.
Topics: Animal Feed; Animals; Anorexia; Body Weight; Energy Intake; Feeding Behavior; Fluoxetine; Fructose; | 2006 |
Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice.
Topics: Alloxan; Animals; Antidepressive Agents; Blood Glucose; Female; Fluoxetine; Hyperglycemia; Insulin; | 1999 |
Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms.
Topics: Animals; Blood Glucose; Enzyme Inhibitors; Fenclonine; Fluoxetine; Fluvoxamine; Hyperglycemia; Insul | 1999 |
Effects of serotonin and fluoxetine on blood glucose regulation in two decapod species.
Topics: Animals; Astacoidea; Blood Glucose; Brachyura; Crustacea; Fluoxetine; Free Radical Scavengers; Hemol | 2001 |
Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity.
Topics: Animals; Anxiety; Body Weight; Brain; Brain-Derived Neurotrophic Factor; Fasting; Fluoxetine; Gene D | 2001 |